Oral desensitization in patients with chronic tophaceous gout and allopurinol hypersensitivity.
Gillott
T J
TJ
Whallett
A
A
Zaphiropoulos
G
G
D000284:Administration, Oral; D000368:Aged; D000493:Allopurinol / Q000008:administration & dosage* / Q000009:adverse effects; D002908:Chronic Disease; D003888:Desensitization, Immunologic / Q000379:methods*; D004342:Drug Hypersensitivity / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D006073:Gout / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D006074:Gout Suppressants / Q000008:administration & dosage* / Q000009:adverse effects; D006331:Heart Diseases / Q000150:complications; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications; D014508:Urea / Q000097:blood
D006074:Gout Suppressants; D000493:Allopurinol; D014508:Urea